Weitz; Jeffrey I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weitz; Jeffrey I..The latest application filed is for "vascular closure devices and methods providing hemostatic enhancement".

Company Profile

2.11.7

Weitz; Jeffrey I. - Ancaster CA
Weitz; Jeffrey I. - Hamilton CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vascular closure devices and methods providing hemostatic enhancement Grant 11,399,815 - Yassinzadeh , et al. August 2, 2	2022-08-02
Vascular Closure Devices And Methods Providing Hemostatic Enhancement App 20190388076 - YASSINZADEH; Zia ; et al.	2019-12-26
Vascular closure devices and methods providing hemostatic enhancement Grant 10,363,021 - Yassinzadeh , et al.	2019-07-30
Vascular Closure Devices And Methods Providing Hemostatic Enhancement App 20170202546 - YASSINZADEH; Zia ; et al.	2017-07-20
Vascular closure devices and methods providing hemostatic enhancement Grant 9,597,066 - Yassinzadeh , et al. March 21, 2	2017-03-21
Vascular Closure Devices and Methods Providing Hemostatic Enhancement App 20160249897 - YASSINZADEH; Zia ; et al.	2016-09-01
Vascular closure devices and methods providing hemostatic enhancement Grant 9,179,897 - Yassinzadeh , et al. November 10, 2	2015-11-10
Heparin compositions that inhibit clot associated coagulation factors App 20080119438 - Weitz; Jeffrey I. ; et al.	2008-05-22
Vascular Closure Devices And Methods Providing Hemostatic Enhancement App 20070276435 - Yassinzadeh; Zia ; et al.	2007-11-29
Methods for preventing neurological events App 20070196347 - Chan; Anthony Kam Chuen ; et al.	2007-08-23
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood Grant 6,780,850 - Dougan , et al. August 24, 2	2004-08-24
Antithrombotic compositions App 20040038932 - Hirsh, Jack ; et al.	2004-02-26
Modified low molecular weight heparin that inhibits clot associated coagulation factors Grant 6,075,013 - Weitz , et al. June 13, 2	2000-06-13
Compositions and methods for inhibiting thrombogenesis Grant 6,001,820 - Hirsh , et al. December 14, 1	1999-12-14
Methods and compositions for diagnosis of hyperhomocysteinemia Grant 5,817,461 - Austin , et al. October 6, 1	1998-10-06
Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics Grant 5,767,269 - Hirsh , et al. June 16, 1	1998-06-16
Compositions and methods for inhibiting thrombogenesis Grant 5,763,427 - Weitz , et al. June 9, 1	1998-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.